Screening for Pancreatic Cancer
Author(s) -
Douglas K Owens,
Karina W. Davidson,
Alex H. Krist,
Michael J. Barry,
Michael D. Cabana,
Aaron B. Caughey,
Susan J. Curry,
Chyke A. Doubeni,
John W. Epling,
Martha Kubik,
C. Seth Landefeld,
Carol M. Mangione,
Lori Pbert,
Michael Silverstein,
Melissa A. Simon,
ChienWen Tseng,
John B. Wong
Publication year - 2019
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2019.10232
Subject(s) - medicine , pancreatic cancer , asymptomatic , cancer , incidence (geometry) , disease , cancer screening , cause of death , oncology , physics , optics
Pancreatic cancer is an uncommon cancer with an age-adjusted annual incidence of 12.9 cases per 100 000 person-years. However, the death rate is 11.0 deaths per 100 000 person-years because the prognosis of pancreatic cancer is poor. Although its incidence is low, pancreatic cancer is the third most common cause of cancer death in the United States. Because of the increasing incidence of pancreatic cancer, along with improvements in early detection and treatment of other types of cancer, it is estimated that pancreatic cancer may soon become the second-leading cause of cancer death in the United States.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom